Table of Contents
1. Executive Summary
2. Global Viral Vector Manufacturing Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1: Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2: Global Viral Vector Manufacturing Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Viral Vector Manufacturing Market by Type
3.3.1: Adenovirus
3.3.2: Retrovirus
3.3.3: Adeno-Associated Virus
3.3.4: Lentivirus
3.3.5: Plasmid DNA
3.3.6: Others
3.4: Global Viral Vector Manufacturing Market by Workflow
3.4.1: Upstream Manufacturing
3.4.2: Downstream Manufacturing
3.5: Global Viral Vector Manufacturing Market by Application
3.5.1: Cell & Gene Therapy
3.5.2: Vaccinology
3.5.3: Research & Other Applications
3.6: Global Viral Vector Manufacturing Market by End Use
3.6.1: Pharmaceutical & Biopharmaceutical
3.6.2: Research Institutes
3.6.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Viral Vector Manufacturing Market by Region
4.2: North American Viral Vector Manufacturing Market
4.2.1: North American Viral Vector Manufacturing Market by End Use: Pharmaceutical & Biopharmaceutical, Research Institutes, and Others
4.3: European Viral Vector Manufacturing Market
4.3.1: European Viral Vector Manufacturing Market by Application: Cell & Gene Therapy, Vaccinology, and Research & Other Applications
4.3.2: European Viral Vector Manufacturing Market by End Use: Pharmaceutical & Biopharmaceutical, Research Institutes, and Others
4.4: APAC Viral Vector Manufacturing Market
4.4.1: APAC Viral Vector Manufacturing Market by Application: Cell & Gene Therapy, Vaccinology, and Research & Other Applications
4.4.2: APAC Viral Vector Manufacturing Market by End Use: Pharmaceutical & Biopharmaceutical, Research Institutes, and Others
4.5: ROW Viral Vector Manufacturing Market
4.5.1: ROW Viral Vector Manufacturing Market by Application: Cell & Gene Therapy, Vaccinology, and Research & Other Applications
4.5.2: ROW Viral Vector Manufacturing Market by End Use: Pharmaceutical & Biopharmaceutical, Research Institutes, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Viral Vector Manufacturing Market by Type
6.1.2: Growth Opportunities for the Global Viral Vector Manufacturing Market by Workflow
6.1.3: Growth Opportunities for the Global Viral Vector Manufacturing Market by Application
6.1.4: Growth Opportunities for the Global Viral Vector Manufacturing Market by End Use
6.1.5: Growth Opportunities for the Global Viral Vector Manufacturing Market by Region
6.2: Emerging Trends in the Global Viral Vector Manufacturing Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Viral Vector Manufacturing Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Viral Vector Manufacturing Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Merck
7.2: Lonza
7.3: FUJIFILM Diosynth Biotechnologies
7.4: Thermo Fisher Scientific
7.5: Cobra Biologics
7.6: Catalent
7.7: Wuxi Biologics
7.8: Takara Bio
7.9: Waisman Biomanufacturing
7.10: Genezen laboratories